Showing 1–24 of 24 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Masoud Arefnezhad, Mahshid Nasehi, Aliakbar Fazaeli, Saeed Sharafi, Rajabali Daroudi
…ACKGROUND:** Tuberculosis (TB) remains a significant global health crisis, regaining its status as the leading cause of death in 2023. Quantifying its economic burden is essential for crafting effective public health strategies. This study aimed to estimate the economic burden of…
Soedarsono S, Mertaniasih NM, Kusmiati T, Permatasari A, Juliasih NN, et al.
…to their family and the wider community, as well as wasting health resources. Prevention and management of LTFU is crucial to reduce mortality, prevent further spread of DR-TB, and inhibit the development and transmission of more extensively drug-resistant strains of bacteria. A …
Chanda E
…ug Resistant Tuberculosis (DR-TB) is one of the main public health and economic problems facing the world today. DR-TB affects mostly those in economically productive years and prevents them from being part of the workforce needed for economic growth. The aim of this study was to…
Mullerpattan JB, Udwadia ZZ, Banka RA, Ganatra SR, Udwadia ZF
Background Private healthcare is choice of point of care for 70% of Indians. Multidrug resistant tuberculosis (MDR-TB) treatment is costly and involves duration as long as 2 years. Aim To estimate costs to patients undergoing treatment for MDR-TB. Methods A health-economics quest…
Li Y, Li Y, Wang T, Li Y, Tao N, et al.
…uberculosis (MDR-TB) has imposed a significant economic and health burden worldwide, notably in China. Using whole genome sequence, we sought to understand the mutation and transmission of MDR-TB in Shandong. A retrospective study of patients diagnosed with pulmonary tuberculosis…
Borham M, Oreiby A, El-Gedawy A, Hegazy Y, Khalifa HO, et al.
… wild animals, representing a worldwide economic and public health burden. The disease is caused by Mycobacterium bovis and infrequently by other pathogenic mycobacteria. The problem of bovine tuberculosis is complicated when the infection is associated with multidrug and extensi…
Kulimbet M, Yergasen A, Glushkova N, Adenov M, Davletov K
… significant impact on economic development, lifestyles and health systems in all countries. Due to the lack of medical interventions, many countries adopted restrictive measures to slow the spread of the virus and reduce the burden on the healthcare system. Quarantine measures h…
Schnippel K, Firnhaber C, Conradie F, Ndjeka N, Sinanovic E
Background Nearly 20,000 people were diagnosed with multi-drug and rifampicin-resistant tuberculosis (MDR/RR-TB) in South Africa in 2015, yet only one-half of the patients who start treatment are expected to have a successful outcome. There is increasing evidence of the effective…
Vo NX, Xuan Doan TB, Kha Vo DN, Tran TK, Vo TQ
…ality of life (QOL). Our purpose is to define the status of health-related QOL for international MDR-TB and XDR-TB patients. Methods Systematic review is a good method for searching and selecting related researches and articles. As such, we have searched for and cited related art…
Francesca Saluzzo, Andrea Maurizio Cabibbe, Richard Anthony, Alexandra Aubry, Francis Drobniewski, et al.
… context-appropriate diagnostic strategies. While the World Health Organisation (WHO) provides model algorithms, these require adaptation to the European Union/European Economic Area (EU/EEA) context, a setting with low TB incidence but high resources. This viewpoint from the Eur…
Dzeyie KA, Basu S, Dikid T, Bhatnagar AK, Chauhan LS, et al.
…Multidrug-resistant tuberculosis (MDR-TB) is a major public health challenge in India. It is associated with poor treatment outcomes, multiple adverse effects to treatment and involves enormous social and economic losses. The objective of the study was to ascertain the epidemiolo…
Mamta Choudhary, Mamta, Pushpa
…erculosis (MDR/XDR-TB) continues to present critical public health and individual challenges, especially in high-burden settings such as India. Despite advancements in diagnostics and therapeutics, individuals affected by MDR/XDR-TB often endure significant psychosocial, economic…
Chen Y, Chen W, Cheng Z, Chen Y, Li M, et al.
…drug-resistant TB requires effective control strategies and healthcare systems.
Xue Y, Zhou J, Wang P, Lan JH, Lian WQ, et al.
…on, marginalization, and social barriers, is a major public health problem. The assessment of TB burden and trend can provide crucial information for policy decision and planning, and help countries in the world to achieve the goal of sustainable development of ending the epidemi…
Song WM, Li YF, Liu YX, Liu Y, Yu CB, et al.
…ially multidrug-resistant tuberculosis (MDR-TB) is a public health threat. Little is known about estimates of different profiles and rates of DR-TB among children globally. Methods: We did a systematic review and meta-analysis of observational studies reporting DR-TB among childr…
Malík I, Čižmárik J, Pecháčová M
…are subsidized by state and regional governments as well as health authorities. Each region has its own specific characteristics and needs specific interventions. Although some novel anti-tuberculosis (anti-TB) drugs (bedaquiline, delamanid) were approved by relevant authorities,…
Diel R, Sotgiu G, Andres S, Hillemann D, Maurer FP
…ethods Hospitalization costs as covered by German statutory health insurance and the loss of productivity due to illness were calculated using the most recent 2018 statistical data. Costs due to combining five agents in the intensive phase and costs of outpatient monitoring were …
Evans D, Hirasen K, Ramushu C, Long L, Sinanovic E, et al.
…re more expensive to both patients and providers. The World Health Organization (WHO) now recommends a new second-line 3-drug 6-month all-oral regimen consisting of bedaquiline, pretomanid, and linezolid referred to as BPaL. We estimate patient and provider costs of DR-TB treatme…
Muniyandi M, Ramesh PM, Wells WA, Alavadi U, Sahu S, et al.
…fits. Conclusion As a lower-cost intervention with improved health outcomes, the BEAT-TB India regimen is dominant when compared to the 18-month regimen.
Paleckyte A, Dissanayake O, Mpagama S, Lipman MC, McHugh TD
…is a leading cause of death from a single infectious agent. Healthcare workers (HCWs) are at increased risk of hospital-acquired TB infection due to persistent exposure to Mycobacterium tuberculosis (Mtb) in healthcare settings. The World Health Organization (WHO) has developed a…
Maciej Michalik, Tomasz Lorenc, Krzysztof Marcinkowski, Mateusz Muras, Natalia Mikszta, et al.
…g-resistant tuberculosis (DR-TB) poses a significant global health threat, particularly in low- and middle-income countries with limited access to quality healthcare. By 2023, 10% of global tuberculosis cases were classified as drug-resistant, with multidrug-resistant (MDR-TB) an…
Santosa A, Juniarti N, Pahria T, Susanti RD
…reatment non-compliance remains a significant global public health issue, undermining disease control efforts and leading to adverse clinical and epidemiological outcomes. While considerable research has explored this issue, gaps remain in understanding the multifactorial influen…
Muhammad Abubakar, Rimsha Mukhtar, Matti Ullah, Mahnoor Irfan
…reversion, and reconversion were defined according to World Health Organization criteria. Treatment costs were calculated using actual drug regimens received by patients and national procurement prices, adjusted to 2024 USD using official exchange rates and inflation indices. Add…
Faye LM, Hosu MC, Apalata T
… The global push to eliminate tuberculosis (TB) as a public health threat is increasingly urgent, particularly in high-burden areas like the Oliver Reginald Tambo District Municipality, South Africa. Drug-resistant TB (DR-TB) poses a significant challenge to TB control efforts an…